Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2026-01-02 @ 11:38 AM
Study NCT ID:
NCT04735432
Status:
COMPLETED
Last Update Posted:
2023-02-28
First Post:
2021-01-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-26
First Submit QC Date:
None
Study First Post Date:
2021-02-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-11-22
Results First Submit QC Date:
None
Results First Post Date:
2023-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-31
Last Update Post Date:
2023-02-28
Last Update Post Date Type:
ACTUAL